How Long Does It Take to Lose Weight?

How long does it take to lose weight is one of the most common questions asked of healthcare professionals, and the honest answer is that it depends on a range of individual factors. For most adults, a safe and sustainable rate is 0.5 to 1 kg per week, consistent with NICE guidance on obesity management. Early losses are often faster due to water and glycogen depletion, while lasting fat loss builds gradually over months. Understanding what influences your pace, and when to seek clinical support, can help you set realistic goals and avoid the cycles of rapid loss and regain that undermine long-term health.

How long does it realistically take to lose weight?

Most adults can expect meaningful weight loss over weeks to months, with NICE guidance supporting a rate of 0.5 to 1 kg per week through calorie reduction and increased physical activity.

Most people can expect to see meaningful weight loss over a period of weeks to months, with the pace varying considerably depending on individual circumstances. A commonly cited clinical benchmark, consistent with NICE guidance on the management of overweight and obesity in adults, is a loss of 0.5 to 1 kg per week when following a structured, calorie-reduced diet combined with increased physical activity. At that rate, losing 5% of body weight, an amount associated with measurable health benefits, is an illustrative calculation based on that benchmark rather than a fixed clinical rule, and the actual timeframe will vary with starting weight and adherence.^[4][1]

It is important to understand that early weight loss is often faster than later weight loss. In the first one to two weeks, much of what is lost is water and glycogen rather than fat tissue, which can make initial progress look more dramatic than it truly is. Sustained fat loss takes longer and requires consistent effort over months rather than days.

For people using licensed weight-management medicines, timelines can differ. Clinical trial data for medicines such as semaglutide (Wegovy) and tirzepatide (Mounjaro) show that significant weight reduction typically accumulates over many months of treatment, with doses escalated gradually according to the prescribing schedule set out in each medicine's Summary of Product Characteristics. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where a range of treatment options may be considered if clinically appropriate.

Realistic expectations matter. Setting a goal of gradual, consistent progress rather than rapid transformation is more likely to result in lasting change and reduces the risk of the cycles of restriction and regain that can undermine long-term health.

What factors affect how quickly you lose weight?

Weight loss rate is shaped by starting weight, age, sex, dietary adherence, physical activity, medical conditions such as hypothyroidism or PCOS, certain medicines, sleep quality and stress levels.

How quickly a person loses weight is shaped by a combination of biological, behavioural and environmental factors, meaning two people following the same plan can achieve very different results. Key influences include:

• Starting weight and body composition: People with a higher starting weight often lose weight more quickly in absolute terms, though the percentage of body weight lost may be similar.

• Age and sex: Metabolic rate tends to decline with age, and hormonal differences between sexes influence how and where fat is stored and mobilised.

• Dietary adherence: The consistency and quality of calorie reduction is one of the strongest predictors of weight loss rate. NICE guidance on obesity management supports a structured approach to calorie reduction, with a deficit of around 500 to 600 kcal per day below maintenance commonly used in clinical practice, though the appropriate level should be agreed with a healthcare professional.

• Physical activity: Exercise contributes to the energy deficit and helps preserve lean muscle mass, which supports a healthier metabolic rate during weight loss.

• Medical conditions: Conditions such as hypothyroidism and polycystic ovary syndrome (PCOS) can slow weight loss; NHS guidance on both conditions notes that managing the underlying condition is an important part of any weight-management plan.^[6] Insulin resistance, which can occur in the context of prediabetes or type 2 diabetes, may also affect weight loss and is best managed with support from a GP or specialist.

• Medicines: Some prescribed medicines, including certain antidepressants, corticosteroids and antipsychotics, are associated with weight gain or difficulty losing weight.^[7][8] The BNF and individual medicine information sheets list weight effects where relevant; speak to a GP or pharmacist if you think a medicine may be affecting your weight.

• Sleep and stress: Poor sleep and chronic psychological stress can influence appetite-regulating hormones, which may increase hunger and affect eating behaviour. NHS guidance on sleep and mental wellbeing provides further information on managing these factors.

Understanding which of these factors applies to you can help set realistic expectations and identify whether additional support, such as a GP review or referral to a specialist weight-management service, might be beneficial.

How much weight loss per week is safe and sustainable?

A rate of 0.5 to 1 kg per week is safe and sustainable for most adults; faster loss through very low-calorie diets requires clinical supervision due to risks including nutrient deficiencies and muscle loss.

A rate of 0.5 to 1 kg per week is widely considered both safe and sustainable for most adults, and this figure is consistent with NICE guidance on the management of overweight and obesity. Losing weight more quickly than this, particularly through very low-calorie diets of fewer than 800 kcal per day, should only be undertaken under clinical supervision, as rapid restriction carries risks including nutrient deficiencies, gallstone formation and loss of lean muscle mass. The NHS provides patient-facing information on very low-calorie diets and the circumstances in which they may be appropriate.

Very low-calorie diets are sometimes used in structured clinical programmes, such as the NHS England Type 2 Diabetes Path to Remission Programme, but these are time-limited and medically supervised. They are not appropriate as a general self-directed approach.

For people using licensed weight-management medicines, the rate of weight loss is influenced by the medicine's mechanism of action and the dose reached. GLP-1 receptor agonists such as semaglutide (Wegovy) and dual GIP and GLP-1 receptor agonists such as tirzepatide (Mounjaro) reduce appetite and slow gastric emptying, supporting a calorie deficit without requiring extreme dietary restriction.^[12][13] Weight loss with these medicines tends to be gradual and cumulative, building over many months of treatment, as described in each medicine's Summary of Product Characteristics.

These medicines are prescription-only and are not suitable for everyone. They should not be used during pregnancy or whilst breastfeeding, and suitability must be assessed by a prescriber before starting treatment. If you experience any suspected side effects whilst taking a weight-management medicine, report them to the MHRA via the Yellow Card scheme (yellowcard.mhra.gov.uk) and seek advice from your prescriber or pharmacist.

Sustainability is as important as speed. Research consistently shows that weight lost slowly, through modest calorie reduction and increased activity, is more likely to be maintained over time. Rapid weight loss is more frequently followed by regain, partly because it triggers compensatory increases in appetite and reductions in metabolic rate. A long-term perspective, aiming for a healthier weight over six to twelve months rather than weeks, is more likely to deliver lasting benefit.

Why might your weight loss slow down or stall?

Plateaus are a normal physiological response as the body adapts to a lower calorie intake, reducing its energy requirements; hormonal changes, gradual dietary drift and reduced movement also contribute.

Weight loss plateaus are extremely common and are a normal physiological response to sustained calorie restriction, not a sign that something has gone wrong. As body weight falls, the body requires fewer calories to function, meaning the same dietary and activity habits that produced a deficit initially will eventually reach a new equilibrium. This metabolic adaptation is well documented and is one of the main reasons weight loss tends to slow after the first few months.

Several other factors can contribute to a stall:

• Gradual increase in calorie intake: Portion sizes and food choices can drift over time without a person noticing, reducing or eliminating the calorie deficit.

• Reduced spontaneous movement: As people lose weight, they often move less throughout the day outside of planned exercise, which reduces overall energy expenditure.

• Hormonal changes: Sustained weight loss triggers changes in appetite-regulating hormones, including a rise in ghrelin (which stimulates hunger) and a fall in leptin (which signals fullness), making it harder to maintain the same level of restriction.

• Stress, sleep disruption or illness: Any of these can temporarily affect weight through fluid retention, hormonal shifts or changes in eating behaviour.

• Medication effects: If a weight-management medicine has been paused, reduced in dose or is no longer producing the same appetite-suppressing effect, weight loss may slow.

If a plateau persists for several weeks despite consistent effort, it is worth reviewing dietary habits, activity levels and any relevant medical factors with a GP or dietitian. This is practical guidance rather than a fixed clinical rule, as the appropriate point to seek a review will depend on individual circumstances. Adjusting the approach, rather than abandoning it, is usually the most productive response.

When should you speak to a GP about losing weight?

Speak to a GP if lifestyle changes have not worked after several months, if you have a BMI of 30 or above, or if an underlying condition such as hypothyroidism may be affecting your weight.

You should speak to a GP about losing weight if lifestyle changes alone have not produced results after several months of consistent effort, or if you have a health condition that may be affecting your weight or making weight loss more difficult. A GP can assess whether an underlying cause, such as hypothyroidism or PCOS, needs to be investigated and treated, and can refer you to specialist weight-management services where appropriate.

Specific situations that warrant a GP appointment include:

• Unexplained weight loss without dietary change or increased activity, which can occasionally indicate an underlying medical condition and should always be investigated.

• A BMI of 30 or above (or 27.5 or above in people of South Asian, Chinese, Middle Eastern, Black African or African-Caribbean family background), where NICE guidance, including NICE public health guidance PH46, supports discussion of medical and pharmacological options. NHS BMI guidance also sets out these lower thresholds for certain ethnic groups.

• Significant obesity-related health conditions such as type 2 diabetes, high blood pressure, obstructive sleep apnoea or joint problems, where weight management is part of broader clinical care.

• Mental health concerns related to eating, body image or weight, which benefit from specialist support alongside any physical health intervention.

For urgent concerns, such as chest pain, severe breathlessness or sudden unexplained weight loss, contact NHS 111 or attend A&E if symptoms are severe.

A GP can also discuss whether a referral to a Tier 3 specialist weight-management service or a prescription medicine is appropriate for your circumstances. NICE technology appraisals have recommended certain medicines for weight management in eligible adults, and your GP or an ICB-commissioned service can advise on local availability and eligibility criteria.^[17][18]

Scientific References

1. Overweight and obesity management (NG246).
2. Overweight and obesity management – Physical activity and diet (NG246 chapter).
3. Overweight and obesity management (NG246 full guideline PDF).
4. Probability of 5% or Greater Weight Loss or BMI Reduction (Kompaniyets et al.).
5. Glycogen storage: illusions of easy weight loss, excessive weight regain, and distortions in estimates of body composition (Kreitzman et al.).
6. Overweight and obesity.
7. Antidepressant drugs – Treatment summaries (BNF/NICE).
8. Psychoses and related disorders – Treatment summaries (BNF/NICE).
9. Effects of antidepressant and antipsychotic use on weight (Alonso-Pedrero et al.).
10. Obesity – Treatment summaries (BNF/NICE).
11. Early findings from the NHS Type 2 Diabetes Path to Remission Programme (Valabhji et al.).
12. Wegovy (semaglutide) – EPAR product information.
13. GLP-1 medicines for weight loss and diabetes: what you need to know.
14. Tirzepatide – Drugs (BNF/NICE).
15. Tirzepatide (NHS medicines information).
16. Overweight and obesity management – NG246 appendix A1 (surveillance, formerly PH46).
17. Tirzepatide for managing overweight and obesity (TA1026).
18. A guide for prescribing medicines to manage overweight and obesity (TA1026 resource).

Frequently Asked Questions